Use of Cephalon, Inc.'s Provigil Could be Limited in Europe

Reuters -- European health regulators recommended on Thursday restricting the use of Cephalon’s (CEPH.O) sleep disorder drug Provigil for treating narcolepsy only, over concerns that risks may outweigh the benefits of the medicine in other uses.

MORE ON THIS TOPIC